Magnesium and norepinephrine for septic shock
Treatments studied
Part of Infections clinical trials.
This trial tests whether raising magnesium levels in the blood to the upper end of normal can reduce the amount of norepinephrine (a medicine to raise blood pressure) needed in patients with septic shock who are already on steroids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have septic shock that is not improving with standard treatment
- You must be receiving corticosteroids for shock
- You cannot be pregnant
- Your blood magnesium level must not be high at the start
- Your kidney function must be above a certain level
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.
This trial studies how norepinephrine affects the heart and circulation in adults with septic shock whose blood pressure stays low after the first day. It may help doctors better choose and adjust medicines to support blood pressure and organ function.
This trial tests different combinations of blood pressure medicines given to patients on a breathing machine who have septic shock. The goal is to find the best dose of a second medicine when norepinephrine alone isn't enough.
This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.
This study tests two blood pressure-raising medicines, norepinephrine and angiotensin-II, in people with septic shock. It aims to see which one works better to improve blood flow and oxygen delivery to organs.
This trial is testing whether a medication called methylene blue can help people with severe septic shock who are already on strong blood pressure support (norepinephrine). The goal is to see if it improves survival and reduces the need for other treatments.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.